Resmed Inc Stock Current Ratio
| RME Stock | EUR 222.20 1.40 0.63% |
ResMed Inc fundamentals help investors to digest information that contributes to ResMed's financial success or failures. It also enables traders to predict the movement of ResMed Stock. The fundamental analysis module provides a way to measure ResMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ResMed stock.
ResMed |
ResMed Inc Company Current Ratio Analysis
ResMed's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current ResMed Current Ratio | 2.06 X |
Most of ResMed's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ResMed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, ResMed Inc has a Current Ratio of 2.06 times. This is 29.21% lower than that of the Healthcare sector and 41.14% lower than that of the Medical Instruments & Supplies industry. The current ratio for all Germany stocks is 4.63% higher than that of the company.
ResMed Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ResMed's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics of similar companies.ResMed is rated fourth in current ratio category among its peers.
ResMed Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 31.17 B | |||
| Shares Outstanding | 146.91 M | |||
| Shares Owned By Insiders | 1.29 % | |||
| Shares Owned By Institutions | 66.53 % | |||
| Price To Earning | 41.49 X | |||
| Price To Book | 9.40 X | |||
| Price To Sales | 8.54 X | |||
| Revenue | 3.58 B | |||
| Gross Profit | 2.06 B | |||
| EBITDA | 1.19 B | |||
| Net Income | 779.44 M | |||
| Cash And Equivalents | 147.13 M | |||
| Cash Per Share | 1.03 X | |||
| Total Debt | 765.33 M | |||
| Debt To Equity | 61.30 % | |||
| Current Ratio | 2.06 X | |||
| Book Value Per Share | 25.45 X | |||
| Cash Flow From Operations | 351.15 M | |||
| Earnings Per Share | 5.17 X | |||
| Price To Earnings To Growth | 1.74 X | |||
| Target Price | 261.67 | |||
| Number Of Employees | 8.16 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 29.28 B | |||
| Total Asset | 5.1 B | |||
| Z Score | 22.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.34 % | |||
| Net Asset | 5.1 B | |||
| Last Dividend Paid | 1.72 |
About ResMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in ResMed Stock
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.